The White House Office of Management and Budget (OMB) on 8 February completed its regulatory review of the US Food and Drug Administration’s draft harmonized Quality System Regulation.
The OMB finished its review in a swift 35 days. The FDA had sent the draft rule to the office on 5 January after working on it for nearly four years
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?